Go Pro

First Tracks Biotherapeutics (TRAX) Earnings Date, Estimates & Call Transcripts

$44.04 +0.01 (+0.02%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$44.10 +0.05 (+0.12%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

First Tracks Biotherapeutics Earnings Summary

First Tracks Biotherapeutics posted Q2 2026 earnings on August 12, 2026, reporting an EPS of -$0.95, which missed analysts' consensus estimates of -$0.74 by $0.21. With a trailing EPS of -$1.84, First Tracks Biotherapeutics' earnings are expected to grow next year, from ($3.42) to ($2.99) per share.

Consensus EPS
(Aug. 12)
-$0.74
Actual EPS
(Aug. 12)
-$0.95 Missed By -$0.21

Q2 2026 Earnings Resources

Get First Tracks Biotherapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on First Tracks Biotherapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

First Tracks Biotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.84-$0.84-$0.84
Q2 20261-$0.86-$0.86-$0.86
Q3 20261-$0.96-$0.96-$0.96
Q4 20261-$1.00-$1.00-$1.00

First Tracks Biotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026-$0.74-$0.95 -$0.21-$0.95--

First Tracks Biotherapeutics Earnings - Frequently Asked Questions

First Tracks Biotherapeutics (NASDAQ:TRAX) last announced its quarterly earning data on Wednesday, August 12, 2026. Learn more on TRAX's earnings history.

In the previous quarter, First Tracks Biotherapeutics (NASDAQ:TRAX) missed the analysts' consensus estimate of ($0.74) by $0.21 with a reported earnings per share (EPS) of ($0.95). Learn more on analysts' earnings estimate vs. TRAX's actual earnings.

First Tracks Biotherapeutics' earnings are expected to grow from ($3.42) per share to ($2.99) per share in the next year.


Earnings data for NASDAQ:TRAX is sourced from Fiscal.ai, with the most recent quarter reported on 8/12/2026. New results are added as companies report their earnings.
From Our Partners